Literature DB >> 11494364

Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.

H Ishiguro1, K Yamada, H Sawada, K Nishii, N Ichino, M Sawada, Y Kurosawa, N Matsushita, K Kobayashi, J Goto, H Hashida, N Masuda, I Kanazawa, T Nagatsu.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene. To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats. Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues. One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission. Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse. Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice. The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients. Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death. The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients. The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494364     DOI: 10.1002/jnr.1153

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  25 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 2.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 3.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

Review 4.  Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.

Authors:  Daman Kumari; Rachel Lokanga; Dmitry Yudkin; Xiao-Nan Zhao; Karen Usdin
Journal:  Biochim Biophys Acta       Date:  2012-01-05

5.  Genome-wide RNAi screen and in vivo protein aggregation reporters identify degradation of damaged proteins as an essential hypertonic stress response.

Authors:  Keith P Choe; Kevin Strange
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-01       Impact factor: 4.249

6.  Mutant huntingtin impairs Ku70-mediated DNA repair.

Authors:  Yasushi Enokido; Takuya Tamura; Hikaru Ito; Anup Arumughan; Akihiko Komuro; Hiroki Shiwaku; Masaki Sone; Raphaele Foulle; Hirohide Sawada; Hiroshi Ishiguro; Tetsuya Ono; Miho Murata; Ichiro Kanazawa; Nikolai Tomilin; Kazuhiko Tagawa; Erich E Wanker; Hitoshi Okazawa
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

7.  Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age.

Authors:  Amanda G Mason; Stephanie Tomé; Jodie P Simard; Randell T Libby; Theodor K Bammler; Richard P Beyer; A Jennifer Morton; Christopher E Pearson; Albert R La Spada
Journal:  Hum Mol Genet       Date:  2013-11-03       Impact factor: 6.150

Review 8.  Huntington disease models and human neuropathology: similarities and differences.

Authors:  Jean Paul G Vonsattel
Journal:  Acta Neuropathol       Date:  2007-11-03       Impact factor: 17.088

9.  Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.

Authors:  Michelle Gray; Dyna I Shirasaki; Carlos Cepeda; Véronique M André; Brian Wilburn; Xiao-Hong Lu; Jifang Tao; Irene Yamazaki; Shi-Hua Li; Yi E Sun; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

Review 10.  The energetics of Huntington's disease.

Authors:  Susan E Browne; M Flint Beal
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.